COMMUNIQUÉS West-GlobeNewswire

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
15/01/2026
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presence Next-generation BTK protein degrader APG-3288 receives IND clearance from the U.S. FDA, [...]
BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes due 2033 to Prefund Repayment of Convertible Senior Notes due 2027
14/01/2026
-- The transaction is intended to strengthen the balance sheet, lower interest expense, reduce dilution, and significantly extend debt maturity PALO ALTO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc [...]
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
14/01/2026
Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008) 7-year OS rate of 45% [...]
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
14/01/2026
Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorder BOSTON and LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals [...]
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
14/01/2026
AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide (CGRP) antagonist treatment option for both pediatric and adult patients. 1 ,2 [...]
Biomerica Reports Second Quarter Fiscal 2026 Financial Results
14/01/2026
Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by 14.7% IRVINE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global [...]
New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification
14/01/2026
Lommel / Hamburg, 01/15/2026 – Aqua free , a leading provider of innovative drinking-water hygiene solutions, has successfully moved into its new, state-of-the-art facility in Lommel and has now also obtained ISO 9001 [...]
Aviv Clinics Becomes First Undersea & Hyperbaric Medical Society Accredited Center Focused on Treating Emerging Indications in the U.S.
14/01/2026
The accreditation underscores Aviv Clinics’ leadership in clinical excellence, patient safety, and scientific innovation in hyperbaric medicine ORLANDO, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aviv Clinics , one of the [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Decembre 2025
14/01/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - December 2025
14/01/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Ensora Health Becomes New Corporate Partner of ASHA
14/01/2026
Partnership Will Enhance Member SLP Care Through Streamlined Workflow Rockville, MD, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The American Speech-Language-Hearing Association (ASHA) announced today that Ensora Health—the [...]
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
14/01/2026
First data on blood-based mRNA signature for pancreatic ductal adenocarcinoma (PDAC) detection and intraductal papillary mucinous neoplasms (IPMN) differentiation to be presented in San Diego BERKELEY, Calif. and , Jan [...]
Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation
14/01/2026
Access the segment here SOUTH SAN FRANCISCO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and [...]
Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer
14/01/2026
Accomplished financial executive brings over 35 years of experience in public and private sector MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company dedicated to [...]
HealthTab™ to Expand Across North East London
14/01/2026
VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) today announced the planned expansion of its HealthTab™ platform across North East [...]
SoldierStrong Announces 2025 Recipients of Annual Individual Commitment to Service Award
14/01/2026
STAMFORD, Conn., Jan. 14, 2026 (GLOBE NEWSWIRE) -- SoldierStrong, the national nonprofit committed to delivering revolutionary medical technologies to America’s veterans, is proud to announce the individual co- [...]
Eagle Pharmaceuticals Announces Divestiture of Barhemsys
14/01/2026
WOODCLIFF LAKE, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the divestiture of the marketing authorization for Barhemsys ( [...]
TellDx-Enabled Circulating Tumor Cell Analysis Predicts Response to DLL3-Targeted Therapy in Small Cell Lung Cancer
14/01/2026
-- Study Results Support the use of TellDx to Personalize Cancer Care Management – -- Clinical study published in Cancer Discovery -- ANDOVER, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- TellBio, Inc., a medical technology [...]
Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilities
14/01/2026
THE HAGUE, The Netherlands, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Affidea Group, Europe’s leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including oncology, [...]

Pages